Chemiluminescence Immunoassay Market, by Product Type (Analyzers (Automated, Semi-automated), Reagents (Luminophore Markers, Enzymatic Markers), and Consumables), by Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious

Chemiluminescence Immunoassay Market, by Product Type (Analyzers (Automated, Semi-automated), Reagents (Luminophore Markers, Enzymatic Markers), and Consumables), by Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, and Others), by End User ( Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Chemiluminescent immunoassay (CLIA) is a biochemical technique used in immunology that is a variation of the standard enzyme immunoassay (EIA). They can also be used as diagnostic tools in medicine, as well as in a variety of other industries such as for food safety and pharmaceutical analysis, environmental monitoring, and many more.
There are two type of chemiluminescence immunoassay methods:
Indirect CLIA with enzyme markers- An enzyme, typically horse radish peroxidase (HRP) or alkaline phosphatase (AP), is conjugated to a secondary antibody in this common CLIA method.
Direct CLIA with luminophore markers- To generate a signal, acridinium esters are commonly used as luminophores and are conjugated directly to the primary monoclonal antibody.

Market Dynamics

Market players are focused on supplying products to hospitals and government organizations, this could contribute to the growth of the global chemiluminescence immunoassay market over the forecast period. For instance, on June 22, 2021, Abbott Laboratories, located in Mumbai, India, began to distribute its laboratory-based serology blood test for the detection of the antibody IgG (Immunoglobulin G), which determines whether a person has been infected with the novel coronavirus (COVID-19). Abbott has the capacity to supply millions of tests to India and has delivered antibody tests to leading government and private hospitals and labs in Maharashtra, Delhi, West Bengal, Uttar Pradesh, Jammu & Kashmir, and Gujarat. The SARS-CoV-2 IgG test from Abbott can be used for highly reliable, large-scale antibody testing, as recommended by the ICMR (Indian Council of Medical Research) for the use of IgG CLIA (Chemiluminescence immunoassay) tests.

Market players focused on product launches is expected to propel the growth of the global chemiluminescence immunoassay market. For instance, on July 25, 2019, STRATEC SE, a global company that develops and manufactures analyzer systems and automation systems for in-vitro diagnostics, has taken another step toward diversifying its product portfolio by introducing stand-alone modules and a new chemiluminescence immunoassay KleeYa. The KleeYa analyzer is an open platform system that can be used by a variety of providers.

Market players and government authorities are involved in expanding their global presence by adopting strategies such as acquisitions and collaborations, is expected to drive the growth of the global chemiluminescence immunoassay market. For instance, on November 16, 2021, Biomedical Advanced Research and Development Authority (BARDA), U.S. expanded its existing partnership with DiaSorin Inc. in the development of COVID-19 immunoassays. DiaSorin plans to develop and sell its new fully automated chemiluminescence immunoassay in the U.S. and around the world and obtain regulatory approval for semi-quantitative detection of SARS CoV2 virus IgG antibodies in human serum and plasma. The test is designed to help determine the patient's exposure and immune status to the SARSCoV2 virus and COVID-19.

Key features of the study:
This report provides an in-depth analysis of global chemiluminescence immunoassay market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global chemiluminescence immunoassay market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Tosoh Corporation, and Ortho Clinical Diagnostic.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global chemiluminescence immunoassay market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global chemiluminescence immunoassay market

Detailed Segmentation:
Global Chemiluminescence Immunoassay Market, By Product Type:
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
Global Chemiluminescence Immunoassay Market, By Application :
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Others
Global Chemiluminescence Immunoassay Market, By End User:
Hospitals
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Others
Global Chemiluminescence Immunoassay Market, By Region:
North America
By Product Type:
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
By Application:
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Others
By End User:
Hospitals
Clinical Laboratory
Pharmaceutical and Biotechnology Companies
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
By Application:
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Others
By End User:
Hospitals
Clinical Laboratory
Pharmaceutical and Biotechnology Companies
Others

By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
By Application:
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Others
By End User:
Hospitals
Clinical Laboratory
Pharmaceutical and Biotechnology Companies
Others
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
By Application:
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Others
By End User:
Hospitals
Clinical Laboratory
Pharmaceutical and Biotechnology Companies
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East
By Product Type:
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
By Application:
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Others
By End User:
Hospitals
Clinical Laboratory
Pharmaceutical and Biotechnology Companies
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
By Application:
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Others
By End User:
Hospitals
Clinical Laboratory
Pharmaceutical and Biotechnology Companies
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others

By Country/Region:
South Africa
Central Africa
North Africa

Company Profiles
DiaSorin S.p.A.*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Abbott Laboratories
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers
Beckman Coulter Inc.
F. Hoffmann-La Roche AG
Inova Diagnostics, Inc.
Maccura Biotechnology Co., Ltd.
Tosoh Corporation
Ortho Clinical Diagnostic

“*” marked represents similar segmentation in other categories in the respective section.